Lene H Harritshøj1, Dorte K Holm2, Susanne G Saekmose3, Bitten A Jensen4, Boris M Hogema5, Thea K Fischer6, Sofie E Midgley6, Jesper S Krog7, Christian Erikstrup8, Henrik Ullum1. 1. Department of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. 2. Department of Clinical Immunology, Odense University Hospital, Odense, Denmark. 3. Department of Clinical Immunology, Naestved Hospital, Naestved, Denmark. 4. Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark. 5. Departments of Blood-borne Infections and Virology, Sanquin Research and Diagnostic Services, Amsterdam, the Netherlands. 6. Virus Surveillance and Research Section, Statens Serum Institute, Copenhagen, Denmark. 7. Section for Diagnostics and Scientific Advice, National Veterinary Institute, Copenhagen, Denmark. 8. Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
Abstract
BACKGROUND: Hepatitis E virus genotype-3 (HEV-gt-3) causes autochthonous infections in western countries, with a primary reservoir in animals, especially pigs. HEV transfusion transmission has been reported, and HEV-gt-3 prevalence is high in some European countries. The prevalence of HEV RNA was investigated among Danish blood donors, and the prevalence of HEV transfusion-transmitted infection (TTI) was investigated among recipients. STUDY DESIGN AND METHODS: Samples from 25,637 consenting donors collected during 1 month in 2015 were screened retrospectively using an individual-donation HEV RNA nucleic acid test with a 95% detection probability of 7.9 IU/mL. HEV-positive samples were quantified by real-time polymerase chain reaction and genotyped. Transmission was evaluated among recipients of HEV RNA-positive blood components. Phylogenetic analyses compared HEV sequences from blood donors, symptomatic patients, and swine. RESULTS: Eleven donations (0.04%) were confirmed as positive for HEV RNA (median HEV RNA level, 13 IU/mL). Two donations were successfully genotyped as HEV-gt-3. Only one donor had a travel history outside Europe. Nine of 11 donors were male, but the gender ratio was nonsignificant compared with the total donor population. Seven available recipients tested negative for HEV RNA and anti-HEV immunoglobulin M in follow-up samples. One recipient was HEV RNA-negative but anti-HEV immunoglobulin G-positive. HEV TTI was considered unlikely, but a transfusion-induced secondary immune response could not be excluded. Phylogenetic analysis showed relatively large sequence differences between HEV from donors, symptomatic patients, and swine. CONCLUSIONS: Despite an HEV RNA prevalence of 0.04% in Danish blood donations, all HEV-positive donations carried low viral loads, and no evidence of TTI was found.
BACKGROUND:Hepatitis E virus genotype-3 (HEV-gt-3) causes autochthonous infections in western countries, with a primary reservoir in animals, especially pigs. HEV transfusion transmission has been reported, and HEV-gt-3 prevalence is high in some European countries. The prevalence of HEV RNA was investigated among Danish blood donors, and the prevalence of HEV transfusion-transmitted infection (TTI) was investigated among recipients. STUDY DESIGN AND METHODS: Samples from 25,637 consenting donors collected during 1 month in 2015 were screened retrospectively using an individual-donation HEV RNA nucleic acid test with a 95% detection probability of 7.9 IU/mL. HEV-positive samples were quantified by real-time polymerase chain reaction and genotyped. Transmission was evaluated among recipients of HEV RNA-positive blood components. Phylogenetic analyses compared HEV sequences from blood donors, symptomatic patients, and swine. RESULTS: Eleven donations (0.04%) were confirmed as positive for HEV RNA (median HEV RNA level, 13 IU/mL). Two donations were successfully genotyped as HEV-gt-3. Only one donor had a travel history outside Europe. Nine of 11 donors were male, but the gender ratio was nonsignificant compared with the total donor population. Seven available recipients tested negative for HEV RNA and anti-HEV immunoglobulin M in follow-up samples. One recipient was HEV RNA-negative but anti-HEV immunoglobulin G-positive. HEV TTI was considered unlikely, but a transfusion-induced secondary immune response could not be excluded. Phylogenetic analysis showed relatively large sequence differences between HEV from donors, symptomatic patients, and swine. CONCLUSIONS: Despite an HEV RNA prevalence of 0.04% in Danish blood donations, all HEV-positive donations carried low viral loads, and no evidence of TTI was found.
Authors: Heléne Norder; Cristina Galli; Ellen Magnil; Per Sikora; Elisabet Ekvärn; Kristina Nyström; Lars O Magnius Journal: Intervirology Date: 2018-10-02 Impact factor: 1.763
Authors: Dragoslav Domanović; Richard Tedder; Johannes Blümel; Hans Zaaijer; Pierre Gallian; Christoph Niederhauser; Silvia Sauleda Oliveras; Joan O'Riordan; Fiona Boland; Lene Harritshøj; Maria São José Nascimento; Anna Rita Ciccaglione; Constatina Politis; Cornelia Adlhoch; Benoit Flan; Wahiba Oualikene-Gonin; Guy Rautmann; Paul Strengers; Patricia Hewitt Journal: Euro Surveill Date: 2017-04-20
Authors: Heli Harvala; Patricia E Hewitt; Claire Reynolds; Callum Pearson; Becky Haywood; Kate I Tettmar; Ines Ushiro-Lumb; Susan R Brailsford; Richard Tedder; Samreen Ijaz Journal: Euro Surveill Date: 2019-03
Authors: Boris M Hogema; Renate W Hakze-van der Honing; Michel Molier; Hans L Zaaijer; Wim H M van der Poel Journal: Viruses Date: 2021-06-29 Impact factor: 5.048